Hypoxia-inducible factor 1a (HIF-1a) degradation under normoxia is critical to modulating vascular growth. This degradation is mediated during normoxia by the von Hippel-Lindau tumour suppressor protein (VHL)-E3 ubiquitin ligase in partnership with the E2 enzyme UbcH5. In current models of the functionally similar Skp1, cullin, F-box (SCF)-E3 ligase, the E3 binds the target protein and the E2 catalyses ubiquitin transfer to lysines in an appropriately positioned domain. In the present study, we report that for efficient ubiquitination of HIF-1a to occur, three conserved lysines are required in both the HIF-1a and endothelial Per-ARNT-Sim domain protein (EPAS) sequences. The site of ubiquitin attachment via UbcH5 was mapped, and is shown to involve three HIF-1a lysines, K532, K538 and K547, and the same aligned lysines in EPAS. Only one of these lysines need to be intact for full ubiquitination to occur, analogous to the mechanism of Sic1 ubiquitination by the SCF/Cdc34 complex and further strengthening the functional link between the VHL and SCF-E3 ubiquitin ligases. We also report that lysines can be moved around the HIF-1a sequence with only minor losses in ubiquitination efficiency, thus suggesting HIF-1a and EPAS regulation by hypoxia depends primarily on an interaction with VHL per se, rather than the highly specific positioning of flanking lysine acceptors.
Introduction
The von Hippel-Lindau tumour suppressor protein (VHL) forms part of a larger ubiquitin E3 ligase that is structurally similar to the yeast Skp1, cullin, F-box (SCF) complex. Really Interesting New Gene (RING) protein components of both E3 ligases facilitate the binding of an E2 enzyme, which carries out multiubiquitination of the target while the target is held in place by the substrate recognition component of the ligase (see, Jackson and Eldridge, 2002 , for a review). Although VHL has no intrinsic catalytic activity, its presence is vital in this reaction, as its b-domain, encompassing amino acids (aa) 60-150, and a single helix from aa 194 to 213 forms the target binding interface of all known VHL-E3 ligase substrates (see, Kondo and Kaelin, 2001 , for a review).
The most well-studied target of the VHL-E3 ligase is hypoxia-inducible factor 1a (HIF-1a) and it homologue, endothelial Per-ARNT-Sim domain protein (EPAS) domain protein (also know as HIF-like factor, HLF or HIF-2a). Under normoxic conditions, the VHL-E3 ligase binds to two hydroxylated prolines within the HIF-1a sequence and the protein is subsequently ubiquitinated and destroyed (Epstein et al., 2001; Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001) . As cells are starved of oxygen, the enzymes that hydroxylate this proline are inhibited, VHL binding is lost and HIF-mediated transcription of various vascular growth genes is upregulated (see, Pugh and Ratcliffe, 2003 , for a review). Other cellular targets of VHL have also been found but not all appear to be ubiquitinated, examples being fibronectin (Ohh et al., 1998) , tubulin (Hergovich et al., 2003) and Jade-1 (Zhou et al., 2002) . Mutations in the VHL gene result in aberrant vascular growth, a constellation of cell growth defects, and the overall phenotypic finding that most if not all VHL mutations predispose individuals to a variety of tumours of varying severity and onset (Lonser et al., 2003) .
The mechanism of VHL-E3 ligase-mediated ubiquitination of HIF-1a has been studied previously, and involves binding of the VHL to hydroxylated prolines at position P564 and P402 in the human HIF-1a sequence. Following this, the regions surrounding these prolines are proposed to be ubiquitinated and destroyed by each of the bound VHL-E3 ligases (Epstein et al., 2001; Masson et al., 2001 ).
In the current study, we establish a model for HIF-1a/ EPAS ubiquitination by the VHL-E3 ligase, which involves the use of several conserved lysine acceptors within the HIF-1a and EPAS oxygen-dependent degradation domains (ODDDs). The mode of ubiquitination is similar to that described for the SCF ligase and appears to involve a high degree of spatial flexibility in ubiquitination of the target protein by the E2, UbcH5 enzyme.
Results and discussion
To date, one study has reported that K532 within the HIF-1a ODDD is important for ubiquitination (Tanimoto et al., 2000) . The region in which this lysine is situated is highly conserved between HIF-1a and EPAS from numerous species and is accompanied by two highly conserved lysines at K538 andK547 in the human sequence ( Figure 1a) . Although there are lysines from 580 to 650 of the HIF-1a sequence, they do not align with the EPAS sequence and, in general, the region is poorly conserved, although one study has reported a lysine acceptor at position K568 in the HIF-3a sequence (Maynard et al., 2003) , which does not align with any lysines in the HIF-1a sequence. Based on this information, it is reasonable to propose that the HIF-1a ubiquitination domain lies somewhere within the aa 500-580 region. Using purified HIF-ODDD and VHL-E3 ligase, we mutated the lysines within this domain either individually or collectively. As shown in Figure 1b , only the removal of all three lysines at K532, K538 and K547 (KKK/RRR) abolished HIF-1a ubiquitination. By contrast, individual point mutations of these lysines had no effect on ubiquitination of the HIF-ODDD. The UbcH5 recruited by VHL-E3 is thus able to find alternate lysine acceptors within this domain on which to attach ubiquitin moieties. To further resolve whether the UbcH5 selected lysine pairs within the ODDD, we mutated the three further pairwise lysine combinations and found these to exhibit the same ubiquitination rate as the wild-type HIF-ODDD (Figure 1c) . The UbcH5 E2 ligase, therefore, requires only one free lysine acceptor within this domain for effective ubiquitination to occur.
The fact that an E2 enzyme may select multiple lysines for ubiquitin attachment has been reported previously. Most notably, and with reference to the SCF ligase, a study showed that Cdc34, the corresponding SCF ligase E2 enzyme, was able to ubiquitinate multiple N-terminal lysines within the Sic1 target protein (Petroski and Deshaies, 2003) . Interestingly, not all lysines produced ubiquitin chains that were degraded at the same rate by the 26S proteasome, implying fast and slow rates of ubiquitin-mediated degradation. In the present study, we observed no difference in the ubiquitin conjugates formed at any of the lysines, although we did not test their removal by the 26S proteasome. Repeating these experiments using the corresponding EPAS-ODDD (Figure 2a ), the same findings were obtained, suggesting that the method and position of ubiquitin attachment to either HIF-1a or EPAS by the VHL-E3/UbcH5 complex is conserved. Moreover, this is likely to extend to other HIF-1a orthologues, as even though several contain only one lysine, this would be sufficient for ubiquitination Figure 1 Ubiquitin acceptor sites within the HIF-1a-ODDD. In (a), an EclustalW alignment of the minimal C-terminal ODDD of HIF-1a and its homologue EPAS was performed using various eukaryote sequences. Conserved lysines and the 'LAP' motif are highlighted and the lysine positions numbered relative to the human HIF-1a sequence. In (b), point mutations of the three lysines shown in (a) were performed on the minimal C-terminal ubiquitination domain of HIF-1a (aa 500-580, fused to a 6 Â Myc/6 Â His tag). The ODDDs were transfected into 293T cells and ubiquitination assays on the purified protein performed as described at the end of this figure legend. Blots were probed with 9E10 antibody, stripped and re-probed with 12CA5 to detect VHL-glutathione-Stransferase (GST). In (c), assays were repeated using the same procedure as in (b), with forms of the HIF-ODDD carrying dual instead of single lysine mutations. Cell lines and maintenance.The generation and maintenance of stable cell lines have been described previously (Lewis and Roberts, 2003) . Generation and source of cDNA's. Haemaglutin-tagged VHL was the gift of WG Kaelin Jr. Subcloning of this sequence into the EF-IRES-puromycin vector has been described previously (Lewis and Roberts, 2003) . The cDNA encoding the various regions of the HIF-ODDDs used in this study were uniformly subcloned onto a 5 0 cDNA sequence encoding an N-terminal 6 Â Myc/6 Â His tag as described previously (Lewis and Roberts, 2004) . EPAS-ODDDs were generated using identical methods and primers to appropriate regions of the EPAS cDNA sequence. 6 Â Myc/6 Â HIS-tagged full-length HIF-1a was the gift of Dan Peet, University of Adelaide. To generate HA-tagged VHL-GST/EF-IRES-puromycin, the 3 0 end of the VHL cDNA was amplified firstly with a primer encoding a C-terminal 6 Â His tag followed by amplification using another primer containing a thrombin cleavage C-terminal to the 6 Â HIS tag and a 3 0 EcoRI site. This plasmid, HA-VHL-6 Â HIS/Thrombin/EF-IRES-puromycin, was fused to an in-frame cDNA sequence encoding GST. Primer details are available upon request. A plasmid encoding Arabidopsis thaliana E1 activating was the gift of Richard Vierstra and human UbcH5b the gift of Jane Jensen and Alan Weissman. Mutagenesis of HIF-ODDD cDNAs and VHL was performed using the Quickchange method. All cDNAs were sequenced following genetic manipulation. Stable lines were generated using either puromycin or neomycin resistance as described previously (Lewis and Roberts, 2003) . To generate constructs with lysines moved progressively away from the 'optimal' site of ubiquitination at K532, primers incorporating a coded lysine at differing intervals within the primer sequence were used to amplify an HIF-1a template sequence carrying K532R, K538R and K547R, and subcloned onto an N-terminal 6 Â Myc/6 Â His tag using a method described previously (Lewis and Roberts, 2004) . The nearest lysines are denoted as being 1, 7, 9 or 15 aa away from the optimal ubiquitination site at K532R. Ubiquitination assays and VHL-E3 ligase purification. E1 and UbcH5b were expressed and purified as described previously (Hatfield et al., 1990; Jensen et al., 1995) . Ubiquitination assays involved purification of the VHL-E3 ligase with the HIF-ODDD. Briefly, 35 mm dishes of 293T cells were co-transfected with cDNAs encoding VHL-GST (0.5 mg) and 1 mg of HIF-ODDD. Thirty-six hours post-transfection cells were incubated in hypoxia chambers using Oxoid anaerobic sachets for 3 h. Immediately following removal from the chambers, cells were washed with ice-cold phosphate-buffered saline followed by lysis in ice-cold lysis buffer containing 0.1% Triton X-100, 150 mM NaCl, complete protease inhibitor tablet, 20% glycerol, 20 mM Tris-HCl (pH 7.5). After 5 min, cell extracts were spun at 10 000 g to remove nuclear material and cell debris and the supernatant incubated with GST resin for 3 h at 41C. Samples were washed three times with lysis buffer and the resin used for ubiquitination in an assay consisting of an adenosine 5 0 triphosphate regenerating system, 1 mg of ubiquitin, 2 mg of E1, 2 mg of E2, 1 mM dithiothreitol, 5 mM MgCl 2 in 20 mM Tris-HCl (pH 7.5). Typically, 10 ml of bed volume was used in a 100 ml assay volume that was incubated for 3 h at 371C. Reactions were terminated with sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and approximately 30 ml of sample subjected to SDS-PAGE electrophoresis and subsequent immunoblotting with 9E10 (anti-myc IgG). Equal protein loading/extract preparation was determined by using the Pierce BCA protein quantitation kit.
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Mode of action of the VHL-E3 ubiquitin ligase S Paltoglou and BJ Roberts to occur. We extended the search for other lysine acceptors, both N-and C-terminal to aa 500 and 580, respectively (Figure 2b ), but were unable to reconstitute efficient ubiquitination using aa 416-580 or aa 500-650 of HIF-1a when both proteins contained K532R, K538R and K547R (KKK/RRR) mutations. We therefore concluded that the lysines identified at K532, K538 and K547 to be the principal ubiquitin acceptors in the HIF-1a ODDD. To determine whether the VHL-E3 ligase used similarly positioned lysines in the N-terminal ODDD (aa 343-509), we attempted to perform similar assays as described for the C-terminal ODDD. However, we were unable to bind the N-terminal ODDD in our assays, suggesting its affinity is very low for VHL or that it is not significantly hydroxylated unless P564 is also hydroxylated (Chan et al., 2005) . As an alternative, we expressed the N-terminal ODDD in HeLa cells, whereupon DPP-dependent induction was observed ( Figure 2c ). We saw no difference in DPP inducibility when mutations were made individually at K362, K370 and K377 (data not shown); however, when the region up to aa 380 was deleted, the N-terminal ODDD was significantly stabilized, suggesting the collective or dual mutation of these lysines accounts for the major ubiquitin acceptors of hydroxyproline 402-bound VHL-E3 ligase. This is in line with a previous report suggesting that aa 380-416 of HIF-1a can bind but are not ubiquitinated by the VHL-E3 ligase at P402 (Masson et al., 2001) . To determine how the lysine acceptors identified in this study affected HIF-1a regulation in vivo, we generated stable cell lines expressing an extended region of the HIF-1a ODDD (aa 380-650) containing both prolines 402 and 564. When regulation of the KKK/ RRR mutant was examined in 293T cells, we observed a significant reduction in ubiquitin conjugates upon proteasome inhibitor treatment when compared to the non-mutated control (Figure 2d ). Even with this change, the ODDD was still regulated by DPP, suggesting that VHL-mediated binding and degradation occurs, albeit less efficiently. Interestingly, the appearance of an ODDD degradation product from the KKK/RRR form suggests that an alternate pathway of ODDD Mode of action of the VHL-E3 ubiquitin ligase S Paltoglou and BJ Roberts degradation exists when VHL-mediated ubiquitination is impaired. Given that the stability of the KKK/RRR mutant was still governed by VHL binding, we propose that the VHL-E3/UbCH5 complex was still ubiquitinating the HIF-1a ODDD in vivo, even though its 'optimal' acceptor lysines had been mutated. To analyse ubiquitination in the broader context of the HIF-1a molecule, we transfected 293T cells with epitope-tagged HIF-1a and investigated its binding to VHL and concomitant ubiquitination (Figure 3a and b) . In Figure 3a , we showed that KKK/RRR and P402A binds to VHL in a manner indistinguishable from that of wild-type HIF-1a, whereas the binding of the P564A was undetectable. Given this, we considered VHLmediated ubiquitination via P564 and K532, K538 and K547 ubiquitin acceptors to be the primary mode of VHL-mediated ubiquitination in our experiments, even though we saw little or no oxygen-dependent regulation of any of the full-length tagged HIF-1a proteins. To account for the latter observation, it seems likely that transient overexpression of epitope-tagged HIF-1a results in a fraction of HIF-1a that undergoes proline hydroxylation and VHL binding and a second, far more significant fraction that does not, making oxygen regulation of HIF-1a difficult to detect. Moreover, even though we were unable to detect any HIF-1a with a P564A mutation bound to VHL (Figure 3a) , we believe this interaction occurs, particularly with both prolines intact (Chan et al., 2005) , most likely at a level below the sensitivity of binding afforded by the extract preparation used in this study. Even with these limitations, we were able to assess ubiquitination of full-length HIF-1a by oxygen-starving transfected cells for a prolonged period and measuring the rapid appearance of HIF-1a ubiquitin conjugates upon reoxygenation (Figure 3b ). Using this approach, all HIF-1a mutants tested (P402A, P564A, KKK/RRR) exhibited reduced ubiquitination by comparison with wild-type HIF-1a (Figure 3b ). Based on these findings, the KKK/RRR mutant inhibits ubiquitination of full-length HIF-1a in a manner similar to the mutation of either proline 402 or 564. Notably, and in concordance with a previous study (Epstein et al., 2001) and the data presented in Figure 2d , such mutations only partially stabilize HIF-1a. Figure 2 Ubiquitin acceptor sites within the EPAS-ODDD, and relevance of HIF-1a lysine acceptors to ubiquitination of the entire HIF-1a ODDD and stability in vivo. In (a), single or dual point mutations of the three aligned EPAS lysines shown in Figure 1a were performed on the minimal C-terminal ubiquitination domain of EPAS (aa 486-549, fused to a 6 Â Myc/6 Â His tag). The ODDDs were transfected into 293T cells and ubiquitination assays on the purified protein performed as described in Figure 1 . In (b), 293T cells were transfected with C-terminal HIF-ODDD cDNAs encoding aa 416-580 or aa 500-650, or the same proteins carrying K532R, K538R and K547R (KKK/RRR) mutations. ODDDs were purified with co-transfected VHL-GST and ubiquitination assays performed using purified components as described in the legend to Figure 1 . Purified HIF-ODDD was detected using 9E10 antibody, then the filter stripped and re-probed with 12CA5 immunoglobulin G to detect HA-tagged VHL-GST. Assays were performed either in the presence or absence of ubiquitin, or E2 (UbcH5) as shown in the figure. In (c), cDNA's encoding the HIF-1a N-terminal ODDDs (aa 343-509 and 380-509) were fused to an N-terminal 6 Â Myc/6 Â His tag and stably expressed in HeLa cells. Cells were treated with DPP for 3 h, equal protein extracts prepared before SDS-PAGE and immunoblotting using 9E10 antisera. In (d), 293T cells were stably transfected with cDNA's encoding either aa 380-650 of HIF-1a or the corresponding K532R, K538R and K547R mutant (KKK/RRR) fused to 6 Â Myc/6 Â His tag. Equal numbers of cells were treated with either DPP (100 mM) or MG132 (50 mM) for 3 h, cells harvested and WCEs prepared and equal protein samples electrophoresed on 8% SDS-PAGE gels, followed by immunoblotting using 9E10 antibody. Position of ubiquitinated HIF-ODDD and molecular weight standards are as shown.
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To further test the stringency of ubiquitination, we 'walked' lysines down the N-terminal region of the HIF-1a ODDD, away from the legitimate ubiquitination site, and proceeded to investigate ubiquitination (Figure 3c ). Moving the lysine several amino acids away from the original K532 position restored ubiquitination to the KKK/RRR mutant, suggesting that any lysine within reasonable proximity to K532 is a ubiquitin acceptor, although multi-ubiquitin chain formation became less efficient as the lysine was moved further away (up to 15 aa). These data support the concept that E2 attachment by E3 ligases of the RING class is flexible, requiring the juxtaposition of the E2 somewhere near the target lysine/s. Indeed, it is rare that any SCF-mediated ubiquitination reactions use a single lysine acceptor (see, Cardozo and Pagano, 2004 , for a review). Whether this involves E2 release from the VHL-E3 ligase and attack of nearby lysines as has been proposed for SCF/Cdc34 (Deffenbaugh et al., 2003) is unknown. This mechanism may explain some previous findings in the HIF-1a regulation field, as fusion proteins that contain only the minimal binding region of the C-terminal HIF-1a ODDD (aa 549-582) are still highly regulated by oxygen, even though they contain no apparent ubiquitin acceptors (Pugh et al., 1997) . Given the present data, it is likely only the binding of these regions to VHL is necessary, as one of perhaps several lysines in the fusion partner protein may be used as surrogate ubiquitin acceptors in the ubiquitination process. a c b Figure 3 Flexibility of lysine acceptor sites within the HIF-1a ODDD for ubiquitination by the VHL-E3/UbcH5 complex. In (a), cDNA's encoding full-length HIF-1a, KKK/RRR, P402A or P564A were fused to an N-terminal 6 Â Myc/6 Â His tag and transfected into 293T cells stably expressing VHL-GST. Twenty-four hours Following transfection, cells were exposed to hypoxia (o1% O 2 ) for 3 h or hypoxia with the addition of 100 mM DPP. Samples were rapidly re-oxygenated, instantly placed on ice, extracts prepared and VHL-GST purified as described in the Figure 1 legend. VHL capture of epitope-tagged HIF-1a and HIF-1a expression in cell extracts was determined by 6% SDS-PAGE and immunoblotting with 9E10 antisera. In (b), the same experiment described in (a) was carried out, with the exception that before cell harvest and extract preparation, cells were allowed 10 min at 371C and 21% oxygen following hypoxic exposure. Extracts were run on 6% SDS-PAGE gels and immunoblotted with 9E10 antisera. The position of HIF-1a ubiquitin conjugates on the blot is marked. In (c), ubiquitination assays were performed as described in the Figure 1 legend, using either HIF-ODDD/500-580, HIF-ODDD/500-580-KKK/RRR or HIF-ODDD-KKK/RRR with lysines added back to the HIF-ODDD 1 0 , 7 0 , 9 0 or 15 0 aa N-terminal to the K532R lysine. HIF-ODDD conjugates and molecular weight standards are as shown.
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